Source: Clinics. Conference titles: Symposium Advances in Medical Research. Unidades: IQ, FCF, FM
Subjects: GLICOPROTEÍNAS, SARCOMA
ABNT
LEVY, D et al. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. São Paulo: Instituto de Química, Universidade de São Paulo. . Acesso em: 01 out. 2024. , 2007APA
Levy, D., Celestino, A. T., Debes, A., Huachaca, N., Schreier, S., Maranhão, R. C., & Bydlowski, S. P. (2007). 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. São Paulo: Instituto de Química, Universidade de São Paulo.NLM
Levy D, Celestino AT, Debes A, Huachaca N, Schreier S, Maranhão RC, Bydlowski SP. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. 2007 ; 62 S26 res. 052.[citado 2024 out. 01 ]Vancouver
Levy D, Celestino AT, Debes A, Huachaca N, Schreier S, Maranhão RC, Bydlowski SP. 3'-Cholesteryl-oligonucleotide/lipid nanoemulsion complex binds to LDL receptors and inhibits p-glycoprotein expression in a sarcoma cell line. Clinics. 2007 ; 62 S26 res. 052.[citado 2024 out. 01 ]